CYTOF
Altamira Therapeutics Ltd.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 15-12G | 2/27/2026 | View on SEC |
| 6-K | 8/29/2025 | View on SEC |
| 25-NSE | 6/17/2025 | View on SEC |
| 6-K | 6/11/2025 | View on SEC |
| SCHEDULE 13G/A | 5/15/2025 | View on SEC |
| 6-K | 5/9/2025 | View on SEC |
| SCHEDULE 13D/A | 5/6/2025 | View on SEC |
| 20-F | 4/30/2025 | View on SEC |
| 6-K | 4/30/2025 | View on SEC |
| S-8 | 4/4/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CYTOF |
| Company Name | Altamira Therapeutics Ltd. |
| CIK | 1601936 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | D0 |
| Phone | 41 (0) 41 729 71 94 |